Page 5 - Deep Track Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Another ADC Developer Lands a Mega Round of Financing for Cancer Clinical Trials

Another ADC Developer Lands a Mega Round of Financing for Cancer Clinical Trials
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomNew zealand generalNew zealandGlasgow cityTorl biotherapeuticsUniversity of pennsylvaniaVertex pharmaceuticalsBristol myers squibbEnterprise associatesJohns hopkins universityPuretech healthNovo holdingsAngeles based torlDeep track capitalPerceptive advisors

Eliem Therapeutics (ELYM) to Acquire Tenet Medicines, Announces Concurrent $120M Private Placement

Eliem Therapeutics (ELYM) to Acquire Tenet Medicines, Announces Concurrent $120M Private Placement
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesWilmer cutler pickering haleWilliam bonificioAndrew levinStephen thomasChris brinzeyExchange commissionDrug administrationTenet medicines incEliem therapeutics incEliem therapeuticsTenet medicinesDeep track capitalBoxer capitalJanus henderson investorsExecutive chairman

Form DEFA14A Eliem Therapeutics, Inc

Form DEFA14A Eliem Therapeutics, Inc
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkNew castle countyState of delawareNew york stock exchangeUnited kingdomSjogren macielWilmer cutler pickering haleAaron davisSrinivas akkarajuInebilizumab amgen tafasitamab incyteDaniels lyonsChris brinzeyNir messafiChristopherd barnstable brownAsaf shinar

TORL secures $158m for oncology pipeline development

Clinical-stage biotechnology company TORL BioTherapeutics has announced the closure of an oversubscribed $158m Series B-2 financing round.

Mark allesBristol myers squibbPerceptive xontogeny venture fundDeep track capitalPerceptive advisorsGoldman sachs alternativesMoore strategic venturesVertex venturesBlue owl healthcare opportunitiesAvidity partners

Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement

Transaction to add clinical-stage program directed towards treating unmet needs in autoantibody-mediated diseases Combined company expected to have approximately $210 million of cash and cash.

United kingdomUnited statesStephen thomasWilliam bonificioWilmer cutler pickering haleAndrew levinChris brinzeyTenet medicines incEliem therapeutics incExchange commissionDrug administrationTenet medicinesDeep track capitalBoxer capitalJanus henderson investorsExecutive chairman